+44(0)1223 750638

GRS@globalregulatoryservices.com

Company Who we are Vacancies Why choose GRS Vision & Mission European SME Status Strategic Partnerships Awards

Biosimilars Biotechnology & Biological Products Borderline Products Cosmetics Europe Generics Herbal Medicines (Europe) Homeopathic Medicines (Europe) Medical Devices & In-Vitro Diagnostics NanoTechnology New Chemical Entities Nutraceuticals Orphan Drugs OTC Medicines Pharmaceuticals

Biotechnology Biological Biosimilar Cosmetics Europe eCTD Generics Herbals & Botanicals (Europe) Herbals & Botanicals (Global) Medical Devices & In-Vitro Diagnostics NanoTechnology Nutraceuticals Orphan Drugs Pharmacovigilance Regulatory Strategy & Support Translation US FDA Support

Professional Bodies Abbreviations Resources

MENU menu

Close

Company Who we are Vacancies Why choose GRS Vision & Mission European SME Status Strategic Partnerships Awards

Industry Sectors

Biosimilars Biotechnology & Biological Products Borderline Products Cosmetics Europe Generics Herbal Medicines (Europe) Homeopathic Medicines (Europe) Medical Devices & In-Vitro Diagnostics NanoTechnology New Chemical Entities Nutraceuticals Orphan Drugs OTC Medicines Pharmaceuticals

Biotechnology Biological Biosimilar Cosmetics Europe eCTD Generics Herbals & Botanicals (Europe) Herbals & Botanicals (Global) Medical Devices & In-Vitro Diagnostics NanoTechnology Nutraceuticals Orphan Drugs Pharmacovigilance Regulatory Strategy & Support Translation US FDA Support

Useful Information

Professional Bodies Abbreviations Resources

GRS Blog

PAST POSTS menu

Close

Nutraceuticals - EU gives Ђ3m to genomic modelling project

Global neutraceutical ingredient market to grow 7.2% pa reaching Ђ18.5 billion by 2015

US and EU: the US FDA and EMA will share work in relation to GMP inspections

UK: consultation on food additives - make sure you have your say

EU: Consumer friendly juice labelling rules approved

Are phone apps the way forward to ensure compliance re food health claims?

The European Commission has issued a concept paper on the requirement for safety features in line with the falsified medicines l

US: New Dietary Ingredient Notifications Guidance - negative response from two key organisations

Antibiotic Action - a UK led global initiative

UK: MHRA sets up a new forum for Good Clinical Practice (GCP)

Global neutraceutical ingredient market to grow 7.2% pa reaching Ђ18.5 billion by 2015

09/1/2012

It looks like this is a market not to be ignored. Do you agree? Please click here for more details.

Author: Greer Deal, Director of Global Regulatory Services (GRS)

Past Posts...

Nutraceuticals - EU gives Ђ3m to genomic modelling project
9 January 2012

Global neutraceutical ingredient market to grow 7.2% pa reaching Ђ18.5 billion by 2015
9 January 2012

US and EU: the US FDA and EMA will share work in relation to GMP inspections
16 December 2011

UK: consultation on food additives - make sure you have your say
16 December 2011

EU: Consumer friendly juice labelling rules approved
16 December 2011

Are phone apps the way forward to ensure compliance re food health claims?
11 December 2011

The European Commission has issued a concept paper on the requirement for safety features in line with the falsified medicines l
7 December 2011

US: New Dietary Ingredient Notifications Guidance - negative response from two key organisations
7 December 2011

Antibiotic Action - a UK led global initiative
11 November 2011

UK: MHRA sets up a new forum for Good Clinical Practice (GCP)
1 November 2011

«previous 5 6 7 8 9 10 11 12 next»